经膈下动脉介入化疗栓塞术治疗原发性肝癌  

Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Via the Inferior Phrenic Artery

作　　者：张帆[1] 孟存良[1] 谷剑[1] 郜利会[1] 靳福昌[1] 

机构地区：[1]河北省人民医院心脏中心导管室,河北石家庄050071

出　　处：《实用放射学杂志》2006年第6期725-727,共3页Journal of Practical Radiology

基　　金：河北省卫生厅科研项目(编号:05371)

摘　　要：目的观察膈下动脉形成肝癌侧枝血供的因素和几率。方法在对137例患者介入治疗中,造影寻找膈下动脉,并超选形成肿瘤血供的膈下动脉,进行化疗栓塞。结果137例患者中有21例经膈下动脉介入治疗(占15.3%),其中原发性肝癌手术切除后复发2例(9.5%),首次介入治疗出现膈下动脉供血3例(14.3%),2次或多次介入治疗后出现膈下动脉供血16例(76.2%)。结论膈下动脉是原发性肝癌的最重要侧枝供血动脉,经膈下动脉介入化疗栓塞原发性肝癌成功率高而且并发症少。Objective To investigate the factors and rate of the forming of the collateral feeding arteries from inferior phrenic artery （ IPA ） in bepatocellular carinoma（HCC ）. Methods IPA was demonstrated on angiographs in 137 patients with HCC during transcatheter arterial chemoembolization （TACE ） , TACE was performed through diaphragmatic inferior artery （DIA ） super setectively. Results Of 137 cases,21 cases underwent TACE through DIA（15. 3% ） ,of them 2 cases were recurrent after surgical operation （ 9.5% ） ,3 cases had the tumor receive blood supply from IPA at first TACE（ 14.3% ） and 16 cases were occured after TACE tow and more times（76.2% ）. Conclusion Collateral branches originated from IPA are important feeding arteries in HCC,TACE of IPA can be performed with a high success rate without major complications.

关 键 词：膈下动脉 原发性肝癌 化疗栓塞 介入治疗 

分 类 号：R735.7[医药卫生—肿瘤] R815[医药卫生—临床医学]